Roche Media 14 oct. 2025 FDA Clears Roche’s Elecsys pTau181 Test for Ruling Out Alzheimer-Related Amyloid Pathology - NeurologyLive #Clears Roche #FDA Clears
Roche Media 13 oct. 2025 Roche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology - PR Newswire #Roche Elecsys #amyloid pathology